PubMed · 8122713
Sodium fluoride therapy.
Abstract
As a medical treatment for otospongiosis-otosclerosis, sodium fluoride influences the underlying bony changes in the labyrinth so as to arrest or prevent the onset of hearing loss. Sodium fluoride is an enzyme inhibitor and reduces osteoclastic bone resorption and, if the dosage is more than 60 mg a day, may rebuild pseudohaversian bone.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
J R Causse, J B Causse, J Uriel, J Berges, G E Shambaugh, P Bretlau. 1993. Sodium fluoride therapy.. https://doi.org/10.1097/00129492-199309000-00013. https://pubmed.health/record/pubmed%3A8122713/sodium-fluoride-therapy
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.